Saturday, 29 May 2010

What's new for 'JKB_daily1' in PubMed

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Sepsis or genomics or altitude: JKB_daily1

Sent on Saturday, 2010 May 29
Search (sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.



PubMed Results
Item 1 of 1

1. Lancet. 2010 May 15;375(9727):1749-51. Epub 2010 Apr 29.

Challenges in the clinical application of whole-genome sequencing.

Ormond KE, Wheeler MT, Hudgins L, Klein TE, Butte AJ, Altman RB, Ashley EA, Greely HT.

Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.

PMID: 20434765 [PubMed - indexed for MEDLINE]
Click here to read

MeSH Terms:

  • Genetic Counseling*/economics
  • Genetic Predisposition to Disease
  • Genetic Testing/economics
  • Genome, Human*
  • Genome-Wide Association Study*/economics
  • Humans
  • Professional-Patient Relations

Friday, 28 May 2010

What's new for 'JKB_daily1' in PubMed

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Sepsis or genomics or altitude: JKB_daily1

Sent on Friday, 2010 May 28
Search (sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.



PubMed Results
Items 1 - 7 of 7

1. Science. 2010 May 14;328(5980):805.

Scientific facilities. Sweden bets on new lab to spruce up its bioscience future.

Travis J.
PMID: 20466895 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • News

MeSH Terms:

  • Biological Science Disciplines*
  • Facility Design and Construction
  • Foundations
  • Genome, Plant*
  • Genomics*
  • Humans
  • Laboratories*
  • Picea/genetics*
  • Sequence Analysis, DNA
  • Sweden
2. Nat Genet. 2010 May;42(5):366-8.

Chipping away at the genetics of smoking behavior.

Amos CI, Spitz MR, Cinciripini P.

Departments of Epidemiology and Behavioral Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. camos@mdanderson.org

Comment on:

Abstract

Three large consortia present comprehensive analyses that identify genetic factors influencing smoking initiation, intensity and cessation. The genetic architecture of these three phases of smoking behavior appears to be largely distinct.

PMID: 20428092 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Comment

MeSH Terms:

  • Chromosome Mapping
  • Family Health
  • Health Behavior
  • Humans
  • Models, Genetic
  • Nicotine/metabolism
  • Pharmacogenetics/methods
  • Receptors, Nicotinic/metabolism
  • Sequence Analysis, DNA
  • Smoking/genetics*
  • Smoking Cessation/methods*
  • Tobacco Use Disorder/genetics*
  • Twin Studies as Topic

Substances:

  • Receptors, Nicotinic
  • Nicotine
3. Nat Genet. 2010 May;42(5):365-6.

Copy number variation and human genome maps.

McCarroll SA.

Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA. mccarroll@genetics.med.harvard.edu

Comment on:

Abstract

Maps of human genome copy number variation (CNV) are maturing into useful resources for complex disease genetics. Four new studies increase the resolution of CNV maps and seek to locate human phenotypic variation on these maps.

PMID: 20428091 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Comment

MeSH Terms:

  • Base Sequence
  • Chromosome Mapping
  • Epigenesis, Genetic
  • Gene Dosage*
  • Genetic Variation
  • Genome
  • Genome, Human*
  • Genomics
  • Humans
  • Linkage Disequilibrium
  • Molecular Sequence Data
  • Mutation
  • Nucleic Acid Hybridization
  • Phenotype
  • Polymorphism, Single Nucleotide
4. Nat Genet. 2010 May;42(5):363.

Conventional wisdom.

[No authors listed]

Abstract

Recent agreement on stable reference sequences for reporting human genetic variants now allows us to mandate the use of the allele naming conventions developed by the Human Genome Variation Society.

PMID: 20428090 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Editorial

MeSH Terms:

  • Alleles
  • Databases, Genetic/standards*
  • Europe
  • Exons
  • Genetic Variation
  • Genetics/standards*
  • Genome
  • Genome, Human*
  • Humans
  • National Library of Medicine (U.S.)
  • Open Reading Frames
  • Programming Languages
  • Software
  • Terminology as Topic
  • United States
5. Nat Genet. 2010 May;42(5):441-7. Epub 2010 Apr 25.

Genome-wide meta-analyses identify multiple loci associated with smoking behavior.

Tobacco and Genetics Consortium.

Collaborators: Furberg H, Kim Y, Dackor J, Boerwinkle E, Franceschini N, Ardissino D, Bernardinelli L, Mannucci PL, Mauri F, Merlini PA, Absher D, Assimes TL, Fortmann SP, Iribarren C, Knowles JW, Quertermous T, Ferrucci L, Tanaka T, Bis JC, Furberg CD, Haritunians T, McKnight B, Psaty BM, Taylor KD, Thacker EL, Almgren P, Groop L, Ladenvall C, Boehnke M, Jackson AU, Mohlke KL, Stringham HM, Tuomilehto J, Benjamin EJ, Hwang SJ, Levy D, Preis SR, Vasan RS, Duan J, Gejman PV, Levinson DF, Sanders AR, Shi J, Lips EH, McKay JD, Agudo A, Barzan L, Bencko V, Benhamou S, Castellsague X, Canova C, Conway DI, Fabianova E, Foretova L, Janout V, Healy CM, Holcátová I, Kjaerheim K, Lagiou P, Lissowska J, Lowry R, Macfarlane TV, Mates D, Richiardi L, Rudnai P, Szeszenia-Dabrowska N, Zaridze D, Znaor A, Lathrop M, Brennan P, Bandinelli S, Frayling TM, Guralnik JM, Milaneschi Y, Perry JR, Altshuler D, Elosua R, Kathiresan S, Lucas G, Melander O, O'Donnell CJ, Salomaa V, Schwartz SM, Voight BF, Penninx BW, Smit JH, Vogelzangs N, Boomsma DI, de Geus EJ, Vink JM, Willemsen G, Chanock SJ, Gu F, Hankinson SE, Hunter DJ, Hofman A, Tiemeier H, Uitterlinden AG, van Duijn CM, Walter S, Chasman DI, Everett BM, Paré G, Ridker PM, Li MD, Maes HH, Audrain-McGovern J, Posthuma D, Thornton LM, Lerman C, Kaprio J, Rose JE, Ioannidis JP, Kraft P, Lin DY, Sullivan PF.

Department of Genetics, University of North Carolina, Chapel Hill, NC 27710, USA.

Comment in:

Abstract

Consistent but indirect evidence has implicated genetic factors in smoking behavior. We report meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium (n = 74,053). We also partnered with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia to follow up the 15 most significant regions (n > 140,000). We identified three loci associated with number of cigarettes smoked per day. The strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3 (rs1051730[A], beta = 1.03, standard error (s.e.) = 0.053, P = 2.8 x 10(-73)). Two 10q25 SNPs (rs1329650[G], beta = 0.367, s.e. = 0.059, P = 5.7 x 10(-10); and rs1028936[A], beta = 0.446, s.e. = 0.074, P = 1.3 x 10(-9)) and one 9q13 SNP in EGLN2 (rs3733829[G], beta = 0.333, s.e. = 0.058, P = 1.0 x 10(-8)) also exceeded genome-wide significance for cigarettes per day. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in BDNF on chromosome 11 (rs6265[C], odds ratio (OR) = 1.06, 95% confidence interval (Cl) 1.04-1.08, P = 1.8 x 10(-8)). One SNP located near DBH on chromosome 9 (rs3025343[G], OR = 1.12, 95% Cl 1.08-1.18, P = 3.6 x 10(-8)) was significantly associated with smoking cessation.

PMID: 20418890 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • Age Factors
  • Alleles
  • Chromosome Mapping
  • Female
  • Genome
  • Genome-Wide Association Study*
  • Genotype
  • Humans
  • Male
  • Molecular Epidemiology/methods
  • Odds Ratio
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Receptors, Nicotinic/genetics
  • Smoking/genetics*

Substances:

  • CHRNA3 protein, human
  • Receptors, Nicotinic

Grant Support:

  • K07 CA118412/CA/NCI NIH HHS/United States
6. Nat Genet. 2010 May;42(5):448-53. Epub 2010 Apr 25.

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.

Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller T, Dieplinger B, Haltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR; ENGAGE Consortium, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K.

[1] deCODE Genetics, Reykjavik, Iceland. [2] Center for Biomolecular Science and Engineering, Jack Baskin School of Engineering, University of California, Santa Cruz, California, USA.

Comment in:

Abstract

Smoking is a common risk factor for many diseases. We conducted genome-wide association meta-analyses for the number of cigarettes smoked per day (CPD) in smokers (n = 31,266) and smoking initiation (n = 46,481) using samples from the ENGAGE Consortium. In a second stage, we tested selected SNPs with in silico replication in the Tobacco and Genetics (TAG) and Glaxo Smith Kline (Ox-GSK) consortia cohorts (n = 45,691 smokers) and assessed some of those in a third sample of European ancestry (n = 9,040). Variants in three genomic regions associated with CPD (P < 5 x 10(-8)), including previously identified SNPs at 15q25 represented by rs1051730[A] (effect size = 0.80 CPD, P = 2.4 x 10(-69)), and SNPs at 19q13 and 8p11, represented by rs4105144[C] (effect size = 0.39 CPD, P = 2.2 x 10(-12)) and rs6474412-T (effect size = 0.29 CPD, P = 1.4 x 10(-8)), respectively. Among the genes at the two newly associated loci are genes encoding nicotine-metabolizing enzymes (CYP2A6 and CYP2B6) and nicotinic acetylcholine receptor subunits (CHRNB3 and CHRNA6), all of which have been highlighted in previous studies of smoking and nicotine dependence. Nominal associations with lung cancer were observed at both 8p11 (rs6474412[T], odds ratio (OR) = 1.09, P = 0.04) and 19q13 (rs4105144[C], OR = 1.12, P = 0.0006).

PMID: 20418888 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • Alleles
  • Aryl Hydrocarbon Hydroxylases/genetics*
  • Cohort Studies
  • Female
  • Genetic Variation*
  • Genome-Wide Association Study
  • Genomics
  • Humans
  • Lung Neoplasms/genetics
  • Male
  • Odds Ratio
  • Phenotype
  • Receptors, Nicotinic/genetics*
  • Smoking/genetics*
  • Tobacco Use Disorder/genetics

Substances:

  • CHRNA6 protein, human
  • CHRNB3 protein, human
  • Receptors, Nicotinic
  • Aryl Hydrocarbon Hydroxylases
  • coumarin 7-hydroxylase

Grant Support:

  • R01 DA 017932/DA/NIDA NIH HHS/United States
7. Nat Genet. 2010 May;42(5):392-9. Epub 2010 Mar 28.

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.

Lincecum JM, Vieira FG, Wang MZ, Thompson K, De Zutter GS, Kidd J, Moreno A, Sanchez R, Carrion IJ, Levine BA, Al-Nakhala BM, Sullivan SM, Gill A, Perrin S.

ALS Therapy Development Institute, Cambridge, Massachusetts, USA.

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Using unbiased transcript profiling in an ALS mouse model, we identified a role for the co-stimulatory pathway, a key regulator of immune responses. Furthermore, we observed that this pathway is upregulated in the blood of 56% of human patients with ALS. A therapy using a monoclonal antibody to CD40L was developed that slows weight loss, delays paralysis and extends survival in an ALS mouse model. This work demonstrates that unbiased transcript profiling can identify cellular pathways responsive to therapeutic intervention in a preclinical model of human disease.

PMID: 20348957 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH Terms:

  • Amyotrophic Lateral Sclerosis/genetics*
  • Amyotrophic Lateral Sclerosis/metabolism
  • Animals
  • CD40 Ligand/antagonists & inhibitors*
  • CD40 Ligand/immunology
  • Disease Models, Animal
  • Female
  • Gene Expression Profiling
  • Humans
  • Immune System
  • Inflammation
  • Macrophages/metabolism
  • Male
  • Mice
  • Mice, Transgenic
  • Signal Transduction
  • Superoxide Dismutase/genetics*
  • Superoxide Dismutase/metabolism

Substances:

  • CD40 Ligand
  • superoxide dismutase 1
  • Superoxide Dismutase

Friday, 21 May 2010

What's new for 'JKB_daily1' in PubMed

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Sepsis or genomics or altitude: JKB_daily1

Sent on Friday, 2010 May 21
Search (sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.



PubMed Results
Items 1 - 11 of 11

1. Nature. 2010 Apr 1;464(7289):757-62.

The genome of a songbird.

Warren WC, Clayton DF, Ellegren H, Arnold AP, Hillier LW, Künstner A, Searle S, White S, Vilella AJ, Fairley S, Heger A, Kong L, Ponting CP, Jarvis ED, Mello CV, Minx P, Lovell P, Velho TA, Ferris M, Balakrishnan CN, Sinha S, Blatti C, London SE, Li Y, Lin YC, George J, Sweedler J, Southey B, Gunaratne P, Watson M, Nam K, Backström N, Smeds L, Nabholz B, Itoh Y, Whitney O, Pfenning AR, Howard J, Völker M, Skinner BM, Griffin DK, Ye L, McLaren WM, Flicek P, Quesada V, Velasco G, Lopez-Otin C, Puente XS, Olender T, Lancet D, Smit AF, Hubley R, Konkel MK, Walker JA, Batzer MA, Gu W, Pollock DD, Chen L, Cheng Z, Eichler EE, Stapley J, Slate J, Ekblom R, Birkhead T, Burke T, Burt D, Scharff C, Adam I, Richard H, Sultan M, Soldatov A, Lehrach H, Edwards SV, Yang SP, Li X, Graves T, Fulton L, Nelson J, Chinwalla A, Hou S, Mardis ER, Wilson RK.

The Genome Center, Washington University School of Medicine, Campus Box 8501, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA. wwarren@watson.wustl.edu

Abstract

The zebra finch is an important model organism in several fields with unique relevance to human neuroscience. Like other songbirds, the zebra finch communicates through learned vocalizations, an ability otherwise documented only in humans and a few other animals and lacking in the chicken-the only bird with a sequenced genome until now. Here we present a structural, functional and comparative analysis of the genome sequence of the zebra finch (Taeniopygia guttata), which is a songbird belonging to the large avian order Passeriformes. We find that the overall structures of the genomes are similar in zebra finch and chicken, but they differ in many intrachromosomal rearrangements, lineage-specific gene family expansions, the number of long-terminal-repeat-based retrotransposons, and mechanisms of sex chromosome dosage compensation. We show that song behaviour engages gene regulatory networks in the zebra finch brain, altering the expression of long non-coding RNAs, microRNAs, transcription factors and their targets. We also show evidence for rapid molecular evolution in the songbird lineage of genes that are regulated during song experience. These results indicate an active involvement of the genome in neural processes underlying vocal communication and identify potential genetic substrates for the evolution and regulation of this behaviour.

PMID: 20360741 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • 3' Untranslated Regions/genetics
  • Animals
  • Auditory Perception/genetics
  • Brain/physiology
  • Chickens/genetics
  • Evolution, Molecular
  • Female
  • Finches/genetics*
  • Finches/physiology
  • Gene Duplication
  • Gene Regulatory Networks/genetics
  • Genome/genetics*
  • Male
  • MicroRNAs/genetics
  • Models, Animal
  • Multigene Family/genetics
  • Retroelements/genetics
  • Sex Chromosomes/genetics
  • Terminal Repeat Sequences/genetics
  • Transcription, Genetic/genetics
  • Vocalization, Animal/physiology

Substances:

  • 3' Untranslated Regions
  • MicroRNAs
  • Retroelements

Grant Support:

  • BBE0175091/Biotechnology and Biological Sciences Research Council/United Kingdom
  • R01 DC007218/DC/NIDCD NIH HHS/United States
  • R01 GM59290/GM/NIGMS NIH HHS/United States
  • R01 NS045264/NS/NINDS NIH HHS/United States
  • R01NS051820/NS/NINDS NIH HHS/United States
  • Howard Hughes Medical Institute/United States
2. Nature. 2010 Apr 1;464(7289):679.

Counterpoint: Data first.

Golub T.

Cancer Program at the Broad Institute, Cambridge, Massachusetts 02142, USA. golub@broadinstitute.org

Comment on:

PMID: 20360719 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Comment

MeSH Terms:

  • Antineoplastic Agents/pharmacology
  • Antineoplastic Agents/therapeutic use
  • Drug Discovery/methods
  • Drug Discovery/trends*
  • Fusion Proteins, bcr-abl/antagonists & inhibitors
  • Fusion Proteins, bcr-abl/genetics
  • Fusion Proteins, bcr-abl/metabolism
  • Genome, Human/genetics*
  • Genomics/trends
  • Humans
  • Individualized Medicine/trends
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/enzymology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics
  • Neoplasms/drug therapy*
  • Neoplasms/genetics*
  • Piperazines/pharmacology
  • Piperazines/therapeutic use
  • Pyrimidines/pharmacology
  • Pyrimidines/therapeutic use

Substances:

  • Antineoplastic Agents
  • Fusion Proteins, bcr-abl
  • Piperazines
  • Pyrimidines
  • imatinib
3. Nature. 2010 Apr 1;464(7289):678.

Point: Hypotheses first.

Weinberg R.

Whitehead Institute for Biomedical Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA. weinberg@wi.mit.edu

Comment in:

PMID: 20360718 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Historical Article

MeSH Terms:

  • Genome, Human/genetics
  • Genomics/economics
  • Genomics/trends
  • History, 20th Century
  • History, 21st Century
  • Human Genome Project/economics
  • Humans
  • Models, Biological*
  • Neoplasms/diagnosis
  • Neoplasms/drug therapy
  • Neoplasms/genetics*
  • Neoplasms/pathology
  • Signal Transduction
  • Systems Biology/economics
  • Systems Biology/trends*
4. Nature. 2010 Apr 1;464(7289):676-7.

Multiple personal genomes await.

Venter JC.

J. Craig Venter Institute, La Jolla, California 92121, USA. jcventer@jcvi.org

PMID: 20360717 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Historical Article

MeSH Terms:

  • Animals
  • Continental Population Groups/genetics
  • Diploidy
  • Female
  • Genetic Predisposition to Disease/genetics
  • Genetic Variation/genetics
  • Genetics, Medical/trends*
  • Genome, Human/genetics*
  • Genomics/economics
  • Genomics/history
  • Genomics/trends*
  • Haploidy
  • Haplotypes/genetics
  • History, 20th Century
  • History, 21st Century
  • Human Genome Project/economics
  • Human Genome Project/history
  • Humans
  • Individualized Medicine/trends*
  • Male
  • Phenotype
  • Sequence Analysis, DNA/economics
  • Sequence Analysis, DNA/history
  • Sequence Analysis, DNA/instrumentation
  • Sequence Analysis, DNA/methods
5. Nature. 2010 Apr 1;464(7289):674-5.

Has the revolution arrived?

Collins F.

National Institutes of Health, Bethesda, Maryland 20892, USA. francis.collins@nih.gov

PMID: 20360716 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Historical Article

MeSH Terms:

  • Access to Information
  • Genetic Predisposition to Disease/genetics
  • Genetics, Medical/trends*
  • Genome, Human/genetics*
  • Genome-Wide Association Study
  • Genomics/economics
  • Genomics/history
  • Genomics/trends*
  • Haplotypes/genetics
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Individualized Medicine/trends*
  • Sequence Analysis, DNA/economics
  • Sequence Analysis, DNA/history
  • Sequence Analysis, DNA/trends
6. Nature. 2010 Apr 1;464(7289):670-1.

Human genome at ten: The sequence explosion.

[No authors listed]
PMID: 20360711 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Historical Article
  • News

MeSH Terms:

  • Archives
  • Databases, Genetic/history
  • Databases, Genetic/statistics & numerical data*
  • Databases, Genetic/trends
  • Female
  • Genome, Human/genetics*
  • Genomics/economics
  • Genomics/history
  • Genomics/methods
  • Genomics/trends*
  • History, 20th Century
  • History, 21st Century
  • Human Genome Project/economics
  • Human Genome Project/history
  • Humans
  • Male
  • Sequence Analysis, DNA/economics
  • Sequence Analysis, DNA/history
  • Sequence Analysis, DNA/methods
7. Nature. 2010 Apr 1;464(7289):668-9.

Human genome at ten: The human race.

Abbott A.
PMID: 20360710 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Historical Article
  • News

MeSH Terms:

  • Animals
  • Computational Biology/economics
  • Computational Biology/history
  • Computational Biology/trends
  • Epigenesis, Genetic
  • Genome, Human/genetics*
  • Genomics/history*
  • Genomics/standards
  • Genomics/trends
  • History, 20th Century
  • History, 21st Century
  • Human Genome Project/history*
  • Humans
  • Metagenome
  • Patents as Topic/history
  • RNA Interference
8. Nature. 2010 Apr 1;464(7289):664-7.

Human genome at ten: Life is complicated.

Check Hayden E.
PMID: 20360709 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Historical Article
  • News

MeSH Terms:

  • Animals
  • Data Mining
  • Gene Expression Regulation
  • Genes/genetics
  • Genome, Human/genetics*
  • Genomics/history
  • Genomics/trends
  • History, 20th Century
  • History, 21st Century
  • Human Genome Project/history
  • Humans
  • Models, Biological*
  • Molecular Biology/history*
  • Neoplasms/genetics
  • Neoplasms/therapy
  • RNA, Untranslated/genetics
  • RNA, Untranslated/metabolism
  • Sea Urchins/embryology
  • Sea Urchins/genetics
  • Systems Biology/trends*
  • Tumor Suppressor Protein p53/chemistry
  • Tumor Suppressor Protein p53/genetics
  • Tumor Suppressor Protein p53/metabolism
  • Uncertainty*

Substances:

  • RNA, Untranslated
  • Tumor Suppressor Protein p53
9. Nature. 2010 Apr 1;464(7289):649-50.

The human genome at ten.

[No authors listed]
PMID: 20360688 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Editorial
  • Historical Article

MeSH Terms:

  • Data Collection
  • Genetic Testing/trends
  • Genetics, Medical/trends*
  • Genome, Human/genetics*
  • Genomics/economics
  • Genomics/history*
  • Genomics/trends
  • Haplotypes/genetics
  • History, 20th Century
  • History, 21st Century
  • Human Genome Project/history*
  • Humans
  • Time Factors
10. J Leukoc Biol. 2010 May;87(5):815-22. Epub 2010 Feb 1.

A conserved distal segment of the mouse CSF-1 receptor promoter is required for maximal expression of a reporter gene in macrophages and osteoclasts of transgenic mice.

Ovchinnikov DA, DeBats CE, Sester DP, Sweet MJ, Hume DA.

Institute for Molecular Bioscience, University of Queensland, Australia.

Abstract

Csf1r mRNA in adult mice is expressed in cells of the macrophage lineage, and during development, it is also expressed from a separate promoter in placental trophoblast cells. This mouse trophoblast promoter sequence is conserved across species, but human trophoblasts actually initiate transcription from a separate promoter 20 kb upstream, which is not conserved in rodents. A 7.2-kb fragment of the mouse Csf1r genomic DNA, including the 3.5-kb promoter, the first coding exon and downstream intron, is sufficient to direct reproducible position- and copy number-independent expression of an EGFP reporter in vitro and in vivo. In this study, we have examined the consequence of removal of the 150-bp fragment encompassing the conserved trophoblast promoter region in the context of the 7.2-kb promoter on reporter gene expression in transgenic mice. The deletion ablated expression in the placenta but also abolished expression in multinucleated OCL and reduced expression in macrophages. RT-PCR analyses of Csf1r mRNA revealed that mouse OCL use another promoter within this region, distinct from that used in placental trophoblasts, to generate an alternative 5'UTR.

PMID: 20123678 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • 5' Untranslated Regions/genetics
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cell Differentiation/genetics
  • Cell Separation
  • Conserved Sequence
  • Female
  • Flow Cytometry
  • Gene Expression
  • Gene Expression Regulation*
  • Genes, Reporter
  • Humans
  • Macrophages/cytology
  • Macrophages/immunology*
  • Macrophages/metabolism
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Osteoclasts/cytology
  • Osteoclasts/immunology*
  • Osteoclasts/metabolism
  • Pregnancy
  • Promoter Regions, Genetic/genetics*
  • RNA, Messenger/analysis
  • Receptor, Macrophage Colony-Stimulating Factor/genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection
  • Trophoblasts/metabolism

Substances:

  • 5' Untranslated Regions
  • RNA, Messenger
  • Receptor, Macrophage Colony-Stimulating Factor

Grant Support:

  • Biotechnology and Biological Sciences Research Council/United Kingdom
11. J Leukoc Biol. 2010 May;87(5):753-64. Epub 2010 Jan 5.

Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products.

Garceau V, Smith J, Paton IR, Davey M, Fares MA, Sester DP, Burt DW, Hume DA.

The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin, United Kingdom.

Comment in:

Abstract

Macrophages are involved in many aspects of development, host defense, pathology, and homeostasis. Their normal differentiation, proliferation, and survival are controlled by CSF-1 via the activation of the CSF1R. A recently discovered cytokine, IL-34, was shown to bind the same receptor in humans. Chicken is a widely used model organism in developmental biology, but the factors that control avian myelopoiesis have not been identified previously. The CSF-1, IL-34, and CSF1R genes in chicken and zebra finch were identified from respective genomic/cDNA sequence resources. Comparative analysis of the avian CSF1R loci revealed likely orthologs of mammalian macrophage-specific promoters and enhancers, and the CSF1R gene is expressed in the developing chick embryo in a pattern consistent with macrophage-specific expression. Chicken CSF-1 and IL-34 were expressed in HEK293 cells and shown to elicit macrophage growth from chicken BM cells in culture. Comparative sequence and co-evolution analysis across all vertebrates suggests that the two ligands interact with distinct regions of the CSF1R. These studies demonstrate that there are two separate ligands for a functional CSF1R across all vertebrates.

PMID: 20051473 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • Amino Acid Sequence
  • Animals
  • Birds
  • Chick Embryo
  • Chickens
  • Conserved Sequence
  • Evolution
  • Finches
  • Gene Expression
  • Humans
  • In Situ Hybridization
  • Interleukins/chemistry
  • Interleukins/genetics*
  • Interleukins/metabolism
  • Macrophage Colony-Stimulating Factor/chemistry
  • Macrophage Colony-Stimulating Factor/genetics*
  • Macrophage Colony-Stimulating Factor/metabolism
  • Macrophages/metabolism*
  • Molecular Sequence Data
  • Phylogeny
  • Protein Structure, Quaternary
  • Receptor, Macrophage Colony-Stimulating Factor/chemistry
  • Receptor, Macrophage Colony-Stimulating Factor/genetics*
  • Receptor, Macrophage Colony-Stimulating Factor/metabolism
  • Sequence Homology, Amino Acid
  • Structural Homology, Protein

Substances:

  • Interleukins
  • interleukin-34, human
  • Macrophage Colony-Stimulating Factor
  • Receptor, Macrophage Colony-Stimulating Factor

Grant Support:

  • BB/D010705/1/Biotechnology and Biological Sciences Research Council/United Kingdom

Wednesday, 19 May 2010

What's new for 'JKB_daily1' in PubMed

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Sepsis or genomics or altitude: JKB_daily1

Sent on Wednesday, 2010 May 19
Search (sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.



PubMed Results
Items 1 - 3 of 3

1. N Engl J Med. 2010 May 13;362(19):1804-13.

Hospital-acquired infections due to gram-negative bacteria.

Peleg AY, Hooper DC.

Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. apeleg@bidmc.harvard.edu

PMID: 20463340 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Review

MeSH Terms:

  • Anti-Bacterial Agents/therapeutic use*
  • Bacteremia/drug therapy
  • Cross Infection/drug therapy*
  • Cross Infection/microbiology*
  • Drug Resistance, Bacterial*/physiology
  • Gram-Negative Bacteria*/isolation & purification
  • Gram-Negative Bacteria*/physiology
  • Gram-Negative Bacterial Infections/drug therapy*
  • Humans
  • Pneumonia, Bacterial/drug therapy
  • Risk Factors
  • Urinary Tract Infections/drug therapy

Substances:

  • Anti-Bacterial Agents
2. Science. 2010 May 7;328(5979):745-8.

Cross-reacting antibodies enhance dengue virus infection in humans.

Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G.

Department of Medicine, Imperial College London, London W12 0NN, UK.

Abstract

Dengue virus co-circulates as four serotypes, and sequential infections with more than one serotype are common. One hypothesis for the increased severity seen in secondary infections is antibody-dependent enhancement (ADE) leading to increased replication in Fc receptor-bearing cells. In this study, we have generated a panel of human monoclonal antibodies to dengue virus. Antibodies to the structural precursor-membrane protein (prM) form a major component of the response. These antibodies are highly cross-reactive among the dengue virus serotypes and, even at high concentrations, do not neutralize infection but potently promote ADE. We propose that the partial cleavage of prM from the viral surface reduces the density of antigen available for viral neutralization, leaving dengue viruses susceptible to ADE by antibody to prM, a finding that has implications for future vaccine design.

PMID: 20448183 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • Aedes
  • Animals
  • Antibodies, Monoclonal/immunology
  • Antibodies, Neutralizing/immunology
  • Antibodies, Viral/immunology*
  • Antibody-Dependent Enhancement*
  • Antigens, Viral/immunology*
  • Cell Line
  • Cross Reactions
  • Dengue/immunology*
  • Dengue Vaccines/immunology
  • Dengue Virus/classification
  • Dengue Virus/immunology*
  • Dengue Virus/physiology
  • Encephalitis Virus, Japanese/immunology
  • Humans
  • Immune Evasion
  • Monocytes/immunology
  • Monocytes/virology
  • Receptors, Fc/immunology
  • Serotyping
  • U937 Cells
  • Viral Envelope Proteins/immunology
  • Viral Matrix Proteins/immunology*
  • Viral Matrix Proteins/metabolism
  • Virus Replication

Substances:

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Viral
  • Dengue Vaccines
  • Receptors, Fc
  • Viral Envelope Proteins
  • Viral Matrix Proteins

Grant Support:

  • Medical Research Council/United Kingdom
  • Wellcome Trust/United Kingdom
3. Science. 2010 May 7;328(5979):697-8.

Immunology. Tumor immune evasion.

Zindl CL, Chaplin DD.

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Comment on:

PMID: 20448171 [PubMed - indexed for MEDLINE]
Related citations
Click here to  read

Publication Types:

  • Comment

MeSH Terms:

  • Animals
  • Antigen-Presenting Cells/immunology
  • B-Lymphocytes/immunology
  • Chemokine CCL21/metabolism
  • Cytokines/metabolism
  • Humans
  • Immune Tolerance
  • Lymphoid Tissue/immunology*
  • Lymphoid Tissue/pathology*
  • Macrophages/immunology
  • Melanoma/immunology*
  • Melanoma/pathology*
  • Mice
  • Stromal Cells/immunology
  • Stromal Cells/pathology
  • T-Lymphocytes/immunology
  • Tumor Escape*

Substances:

  • CCL21 protein, human
  • Chemokine CCL21
  • Cytokines

Tuesday, 18 May 2010

What's new for 'JKB_daily1' in PubMed

This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Sepsis or genomics or altitude: JKB_daily1

Sent on Tuesday, 2010 May 18
Search (sepsis[MeSH Terms] OR septic shock[MeSH Terms] OR altitude[MeSH Terms] OR genomics[MeSH Terms] OR genetics[MeSH Terms] OR retrotransposons[MeSH Terms] OR macrophage[MeSH Terms]) AND ("2009/8/8"[Publication Date] : "3000"[Publication Date]) AND (("Science"[Journal] OR "Nature"[Journal] OR "The New England journal of medicine"[Journal] OR "Lancet"[Journal] OR "Nature genetics"[Journal] OR "Nature medicine"[Journal]) OR (Hume DA[Author] OR Baillie JK[Author] OR Faulkner, Geoffrey J[Author]))
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.



PubMed Results
Items 1 - 3 of 3

1. Nature. 2010 Apr 8;464(7290):831.

PhD: routine technical work of sequencing is no substitute.

Chen Y.

Comment on:

PMID: 20376128 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Comment
  • Letter

MeSH Terms:

  • China
  • Creativeness
  • Education, Graduate/standards*
  • Genomics/education
  • Genomics/manpower
  • Genomics/methods
  • Logic
  • Research Personnel/education*
  • Research Personnel/standards*
  • Sequence Analysis, DNA*
2. Nature. 2010 Apr 8;464(7290):831.

PhD: still necessary for independent research leaders.

Li Y.

Comment on:

PMID: 20376127 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Comment
  • Letter

MeSH Terms:

  • China
  • Education, Graduate*
  • Genomics/manpower
  • Leadership*
  • Research Personnel/education*
  • Research Personnel/standards
3. Nature. 2010 Apr 8;464(7290):927-31. Epub 2010 Feb 17.

Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.

Matsui T, Leung D, Miyashita H, Maksakova IA, Miyachi H, Kimura H, Tachibana M, Lorincz MC, Shinkai Y.

Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, 53 Shogoin, Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

Abstract

Endogenous retroviruses (ERVs), retrovirus-like elements with long terminal repeats, are widely dispersed in the euchromatic compartment in mammalian cells, comprising approximately 10% of the mouse genome. These parasitic elements are responsible for >10% of spontaneous mutations. Whereas DNA methylation has an important role in proviral silencing in somatic and germ-lineage cells, an additional DNA-methylation-independent pathway also functions in embryonal carcinoma and embryonic stem (ES) cells to inhibit transcription of the exogenous gammaretrovirus murine leukaemia virus (MLV). Notably, a recent genome-wide study revealed that ERVs are also marked by histone H3 lysine 9 trimethylation (H3K9me3) and H4K20me3 in ES cells but not in mouse embryonic fibroblasts. However, the role that these marks have in proviral silencing remains unexplored. Here we show that the H3K9 methyltransferase ESET (also called SETDB1 or KMT1E) and the Krüppel-associated box (KRAB)-associated protein 1 (KAP1, also called TRIM28) are required for H3K9me3 and silencing of endogenous and introduced retroviruses specifically in mouse ES cells. Furthermore, whereas ESET enzymatic activity is crucial for HP1 binding and efficient proviral silencing, the H4K20 methyltransferases Suv420h1 and Suv420h2 are dispensable for silencing. Notably, in DNA methyltransferase triple knockout (Dnmt1(-/-)Dnmt3a(-/-)Dnmt3b(-/-)) mouse ES cells, ESET and KAP1 binding and ESET-mediated H3K9me3 are maintained and ERVs are minimally derepressed. We propose that a DNA-methylation-independent pathway involving KAP1 and ESET/ESET-mediated H3K9me3 is required for proviral silencing during the period early in embryogenesis when DNA methylation is dynamically reprogrammed.

PMID: 20164836 [PubMed - indexed for MEDLINE]
Related citations
Click here to read

Publication Types:

  • Research Support, Non-U.S. Gov't

MeSH Terms:

  • Animals
  • Cell Line
  • DNA (Cytosine-5-)-Methyltransferase/deficiency
  • DNA (Cytosine-5-)-Methyltransferase/genetics
  • DNA (Cytosine-5-)-Methyltransferase/metabolism
  • DNA Methylation/genetics
  • Embryonic Stem Cells/enzymology*
  • Embryonic Stem Cells/metabolism
  • Embryonic Stem Cells/virology*
  • Endogenous Retroviruses/genetics*
  • Fibroblasts
  • Gene Deletion
  • Gene Silencing*
  • Histone-Lysine N-Methyltransferase/deficiency
  • Histone-Lysine N-Methyltransferase/genetics
  • Histone-Lysine N-Methyltransferase/metabolism*
  • Mice
  • Nuclear Proteins/metabolism
  • Protein Methyltransferases/deficiency
  • Protein Methyltransferases/genetics
  • Protein Methyltransferases/metabolism*
  • Proviruses/genetics*
  • Repressor Proteins/metabolism

Substances:

  • Nuclear Proteins
  • Repressor Pr oteins
  • Trim28 protein, mouse
  • DNA methyltransferase 3B
  • Protein Methyltransferases
  • SETDB1 protein, mouse
  • histone methyltransferase
  • DNA (Cytosine-5-)-Methyltransferase
  • DNA (cytosine-5-)-methyltransferase 1
  • DNA methyltransferase 3A
  • Histone-Lysine N-Methyltransferase

Grant Support:

  • 77805/Canadian Institutes of Health Research/Canada
  • 92090/Canadian Institutes of Health Research/Canada